|
Volumn 40, Issue 7, 2001, Pages 888-898
|
KCNQ4 channel activation by BMS-204352 and retigabine
|
Author keywords
Epilepsy; Ischemia; KCNQ channels; M current; Retigabine; Stroke
|
Indexed keywords
(5 CHLORO 2 METHOXYPHENYL) 1,3 DIHYDRO 3 FLUORO 6 (TRIFLUOROMETHYL) 2H INDOL 2 ONE;
10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE;
3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE;
LINOPIRDINE;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL STIMULATING AGENT;
RETIGABINE;
UNCLASSIFIED DRUG;
ARTICLE;
CELL MEMBRANE POTENTIAL;
CHANNEL GATING;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG MECHANISM;
EMBRYO;
HUMAN;
HUMAN CELL;
INHIBITION KINETICS;
MEMBRANE CURRENT;
NEUROPROTECTION;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ANTICONVULSANTS;
CARBAMATES;
CELL LINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INDOLES;
KCNQ POTASSIUM CHANNELS;
PHENYLENEDIAMINES;
POTASSIUM CHANNELS;
POTASSIUM CHANNELS, VOLTAGE-GATED;
|
EID: 17144444950
PISSN: 00283908
EISSN: None
Source Type: Journal
DOI: 10.1016/S0028-3908(01)00029-6 Document Type: Article |
Times cited : (118)
|
References (39)
|